June 23, Shengye Capital (stock code: 6069.HK) $SY HOLDINGS (06069.HK)$ Announced the completion of a strategic investment in Shanghai Lingjian Information Technology Co., Ltd. (hereinafter referred to as “Lingjian”).This round of financing is Lingjian's Series D financing, led by Investcorp, a major international investment institution. In addition to Shengye Capital, other co-investors in this round include Jinding Capital, as well as old shareholders Jingwei China, $So-young International (SY.US)$ , Lightspeed China etc. Lingjian completed two rounds of financing totaling more than 100 million US dollars within half a year. Past investment institutions also included Fosun and Taikang, which was recognized by top investment institutions and strategic investors, which is enough proof of Lingjian's market position and development potential in the consumer healthcare “SaaS+ supply chain” field.
As a strategic investor, Shengye Capital and Lingjian simultaneously signed a strategic cooperation agreement, and the two sides will carry out strategic cooperation in supply chain digital finance in the consumer medical field. Shengye Capital will rely on digital technology to provide flexible supply chain finance solutions for enterprises in Lingjian and its supply chain ecosystem to promote the digitization process of the supply chain in consumer health segments such as dentistry, medicine and aesthetics, and assist Lingjian to accelerate the development of the supply chain platform business.

Established in 2015, Lingjian provides integrated management solutions for dental clinics and aesthetic institutions. It provides management software covering the entire clinic business process, such as single store/chain management, health files/electronic medical records, social customer relationship management, intelligent marketing private traffic solutions, intelligent operation, B2B consumables shopping, sales and storage management, insurance payment, and image integration. At the same time, we connect upstream and downstream of the industry through an open platform and cooperate with high-quality third party institutions to provide complete supporting solutions for clinics. Up to now, Lingjian has provided SaaS management software for more than 30,000 dental, medical and aesthetic institutions, including 80% of high-end medical chains. Maintaining rapid growth with rich industry insight and strong technical strength, Lingjian continues to lead the first tier of consumer healthcare SaaS management software. In addition to software services, Lingjian continues to make efforts in the industrial supply chain and has built a “Lingjian Mall” to connect the upstream and downstream of the industry. At present, the Lingjian Mall has connected more than 300 upstream first-tier brands and more than 10,000 SKUs. Choosing the “software+supply chain” dual-drive model also represents Lingjian's determination and patience to become the digital infrastructure of the industry.
As the first supply chain fintech platform listed on Hong Kong stocks, Shengye Capital has been included in the MSCI China Index, Hang Seng Composite Index and Shenzhen-Hong Kong Stock Connect. Major institutional shareholders include $Temasek Holdings (LIST2536.US)$ 、 $CHINA TAIPING (00966.HK)$ , and Tarzan of the United States. Shengye Capital is committed to building digital supply chain services through the dual driving development of industrial technology and digital finance. Use big data analysis to open up information barriers, intelligently link the asset side and capital side, and provide one-stop supply chain SaaS and digital finance solutions for enterprise customers and financial institutions. As a national high-tech enterprise, Shengye's technology platform has been deeply involved in more than 10 large-scale industrial digital ecosystems, with a cumulative accounts receivable asset management scale of over 100 billion yuan, providing flexible supply chain finance services for more than 8,000 micro, small and medium-sized enterprises.
As the first supply chain fintech platform listed on Hong Kong stocks, Shengye Capital has been included in the MSCI China Index, Hang Seng Composite Index and Shenzhen-Hong Kong Stock Connect. Major institutional shareholders include $Temasek Holdings (LIST2536.US)$ 、 $CHINA TAIPING (00966.HK)$ , and Tarzan of the United States. Shengye Capital is committed to building digital supply chain services through the dual driving development of industrial technology and digital finance. Use big data analysis to open up information barriers, intelligently link the asset side and capital side, and provide one-stop supply chain SaaS and digital finance solutions for enterprise customers and financial institutions. As a national high-tech enterprise, Shengye's technology platform has been deeply involved in more than 10 large-scale industrial digital ecosystems, with a cumulative accounts receivable asset management scale of over 100 billion yuan, providing flexible supply chain finance services for more than 8,000 micro, small and medium-sized enterprises.

Regarding this round of financing, Wu Zhijia, founder and CEO of Lingjian, said, “In the domestic consumer healthcare SaaS field, Lingjian is fortunate to have achieved some phased results, thanks to the love, support and help of many partners in the dental and aesthetic industry. The SaaS model has a natural ability to connect people, processes, equipment, and services, which provides a solid digital foundation for our supply chain capabilities. At the same time, by deepening the supply chain and value-added service capabilities, we expect to improve the overall operational efficiency of the industry, build an industrial value network, and accelerate the digital development process of the industry.”
Regarding this strategic investment in Lingjian, Mr. Harano, Chief Strategy Officer of Shengye Capital, said, “We are very appreciative of Mr. Wu and the excellent team of Lingjian. We are also very honored to be able to invest in Lingjian in this round and become their strategic partner. Consumer healthcare SaaS is a circuit we value very much, and Lingjian's innovative model of building a supply chain platform through SaaS fits perfectly with Shengye's strategic layout in the field of industrial technology. In the context of the upgrading of the consumer medicine industry, we will work together to build an industrial digital ecosystem and provide a full range of “SaaS+ supply chain+ digital finance” services for enterprise customers in the ecosystem. At the same time, we will provide industry resources and supply chain financial support for Lingjian to help strengthen its leading position in the industry.”
Recently, Shengye Capital also announced a strategic investment plan. It will carry out strategic investments and mergers and acquisitions in the fields of industrial technology and digital finance to accelerate the Group's digital platform strategy. In this process, the Group will focus on strategic investment opportunities in the fields of industrial SaaS, digital technology, the Internet of Things and supply chain platforms, and is committed to supporting the rapid development of invested enterprises in multiple dimensions through the combination of “equity investment+industrial resource export+supply chain finance”, and building an open partner ecosystem to jointly achieve the mission of “making the supply chain more efficient and finance more inclusive”.
Risk Disclaimer: The above content only represents the author's view. It does not represent any position or investment advice of Futu. Futu makes no representation or warranty.Read more
Comment (1)
to post a comment
1
1
